Skip to main content
Signal8

Regent Pacific Group Limited (RPGLF)

Sector: Medical - Pharmaceuticals

Industry: Medical - Pharmaceuticals

Regent Pacific Group Limited logo

Regent Pacific Group Limited

OTC:RPGLFHealthcare
Mkt Cap-
EV-
Float1.58M
O/S291.82M
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 10, 20260.00590.00590.00590.005940
Nov 9, 20260.00590.00590.00590.005940
Nov 6, 20260.00590.00590.00590.005940
Nov 3, 20260.00590.00590.00590.005940
Nov 2, 20260.00590.00590.00590.005940
Oct 30, 20260.00590.00590.00590.005940
Oct 29, 20260.00590.00590.00590.005940
Oct 26, 20260.00590.00590.00590.005940
Oct 23, 20260.00590.00590.00590.005940
Oct 20, 20260.00590.00590.00590.005940
Oct 19, 20260.00590.00590.00590.005940
Oct 16, 20260.00590.00590.00590.005940
Oct 15, 20260.00590.00590.00590.005940
Oct 12, 20260.00590.00590.00590.005940
Oct 9, 20260.00590.00590.00590.005940
Oct 6, 20260.00590.00590.00590.005940
Oct 5, 20260.00590.00590.00590.005940
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Regent Pacific Group Limited operates as an investment holding company, directing capital towards businesses within the healthcare and life sciences sectors, primarily in European and Taiwanese markets.

The company's activities are organized into two primary divisions: Biopharma and Corporate Investment. Within the Biopharma segment, the focus is on the entire lifecycle of pharmaceutical products, from initial research and development to manufacturing, marketing, and sales, specifically addressing treatments for urological conditions. This division is also involved in developing advanced artificial intelligence systems engineered to quantify the aging rate across molecular, cellular, tissue, organ, systemic, physiological, and psychological aspects. The Corporate Investment division, meanwhile, commits funds to both publicly traded and privately owned entities.

Additionally, the company offers various management services.

Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 291.82M shares outstanding

SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeOTC
CountryHKHK
IPO Date-
Shares Outstanding291.82M
Authorized Shares
Float1.58M
52-Week Range
Volume
Average Daily Volume--

30d Avg

--

60d Avg

--

90d Avg

--

Earnings
Dividend History
No dividend history available